Helix Bridge Life Sciences

Pharmaceutical & Healthcare Consulting for Africa & the Middle East.

Helix Bridge Life Sciences is a life sciences consulting firm working with pharmaceutical companies, biotech, and healthcare organisations to build and grow commercial operations across North Africa, West Africa, and the Middle East. 22+ years on the ground.

Explore Our Services Let's Talk

Science-Led, Practitioner-Delivered

Senior Expertise. Every Engagement.

22+ Years on the Ground in Africa & MEA

Global Standards. Local Execution.

Who We Are

Helix Bridge is a boutique pharmaceutical & healthcare consulting practice run by practitioners who have spent decades building commercial operations in African and Middle Eastern pharma markets — not advising from the outside. We bring senior expertise to every mandate: commercial strategy, commercial excellence, market access, salesforce effectiveness, regulatory advisory, and go-to-market execution across MEA.

Meet the Team

What We Do

Strategy & Portfolio

Corporate strategy, portfolio prioritisation, and go-to-market planning for pharma companies entering or growing in Africa.

Learn More Commercial Effectiveness

Salesforce excellence, marketing effectiveness, and P&L improvement for pharmaceutical commercial teams in Africa and the Middle East.

Learn More Access & Regulatory

Market access strategy, pricing and reimbursement, and regulatory pathway navigation across MEA markets.

Learn More Setup & Launch

Distributor identification, commercial infrastructure setup, and product launch execution for pharma companies entering African markets.

Learn More Organization & Talent

Operating model design, talent development, and fractional executive leadership for pharmaceutical organisations in Africa.

Learn More

Our Approach

We start by listening — because the real challenge is rarely the one described in the first conversation. Our three-phase method moves from deep discovery to bespoke design to hands-on delivery, with senior practitioners present at every stage.

What makes this different: we do not hand over a slide deck and disappear. We stay close to the work until results are visible.

See How We Work

The People Behind Helix Bridge

Helix Bridge was founded on a belief that the best consulting comes from people who have actually done the work — not advised on it from a distance. Our team brings together decades of commercial leadership, medical affairs, market access, and operational experience from within the African pharma industry itself.

Our extended expert network allows us to bring the right specialists to every engagement, at the scale that fits your project — without the overhead of a global firm.

Meet Our Team

Insights & Perspectives

Our thinking on the forces shaping pharma in Africa and the Middle East — written by practitioners, for practitioners.

Go-to-Market Strategy 15 June 2026

The Africa Go-to-Market Model: Why Copy-Paste from Emerging Markets Fails — and What to Build Instead

Pharma companies entering African markets often rely on commercial models borrowed from other emerging markets — Latin America, South-East Asia, Eastern Europe — and are surprised when they underperform. Sub-Saharan and North African markets require purpose-built GTM architectures that account for channel fragmentation, regulatory heterogeneity, and informal distribution dynamics that simply don't exist elsewhere.

Commercial Excellence 15 June 2026

From SFE to P&L: Building a Commercial Excellence Engine That Actually Moves the Numbers

Commercial excellence in African pharma markets is not about installing a CRM or redesigning territories in isolation. It is about connecting salesforce effectiveness, marketing precision, and pricing discipline into an integrated commercial system that delivers measurable P&L improvement. Here is what that connection looks like in practice, and where most organisations break the chain.

Africa Market Intelligence 15 June 2026

Geographical Expansion in Africa: Why On-the-Ground Due Diligence Is the Non-Negotiable First Step

Every year, pharma companies sign distribution agreements in African markets on the strength of desk research, broker recommendations, or regional reputation alone — and most of them pay for it. Genuine market intelligence in Africa requires field visits, health authority conversations, and distributor reference checks that cannot be replicated from a laptop. The companies that expand successfully understand this before they commit.

A focused conversation costs nothing. A wrong market entry decision does.

Or email directly: khalil.allouche@helixbridgels.com

Let's Connect